CD68 and neoplasm: Compared with patients who did not receive chemotherapy, the density of CD3+ T lymphocytes (23.077 ± 14.353 vs. 25.75 ± 15.226, P = 0.565) and CD68+ macrophages (9.685 ± 4.718 vs. 9.852 ± 7.002, P = 0.923) in the tumor tissue of patients receiving neoadjuvant chemotherapy was lower.